Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
NV

NVST

Market Closed

Envista Holdings Corp

NYSEHealthcareMedical - Instruments & Supplies
US
12.00K employees
CEO: Paul A. Keel
Founded: 2019
$27.64
+$0.00(+NaN%)
Market Cap
4.50B
Beta
0.86
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Envista Holdings shows significant undervaluation with a fair value 61.2% above its current price, supported by a high-confidence DCF range and analyst targets. Financial health reveals strong liquidity but weak profitability and efficiency, indicating operational challenges. Monte Carlo analysis presents high volatility and downside risk (30.6%), reflecting considerable uncertainty despite substantial upside potential.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore NVST

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

NVST in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →